doctitl advisori committe notic meet doctitl agenc agenc food drug administr hh agenc action action notic action summari summari notic announc forthcom meet public advisori committe food drug administr fda notic also summar procedur meet method interest person may particip open public hear fda advisori committe meet follow advisori committe meet announc vaccin relat biolog product advisori committe date time place june 7 1994 8 holiday inn_silv spring plaza ballroom 8777 georgia ave silver spring md type meet contact person open public hear 8 9 unless public particip last long open committe discuss 9 1 p close committe deliber 1 p 6 p nanci cherri stephani milwit scientif advisor consult staff hfm21 center biolog evalu research food drug administr 1401 rockvil pike rockvil md 20852 3015941054 gener function committe committe review evalu data safeti effect vaccin intend use diagnosi prevent treatment human diseas agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person may 31 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss committe particip gener discuss clinic develop trial design issu vaccin prevent lyme diseas close committe deliber committe review trade secret confidenti commerci inform relev pend investig new drug ind applic product licens applic portion meet close permit discuss inform 5 u c 552b c 4 anesthet life support drug advisori committe date time place june 9 1994 8 30 june 10 1994 8 confer rm e parklawn bldg 5600 fisher lane rockvil md type meet contact person open public hear june 9 1994 8 30 9 30 unless public particip last long open committe discuss 9 30 5 p open committe discuss june 10 1994 8 9 close committe deliber 9 5 p isaac f roubein center drug evalu research hfd7 food drug administr 5600 fisher lane rockvil md 20857 3014433741 gener function committe committe review evalu data safeti effect market investig human drug use field anesthesiolog surgeri agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person may 31 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss june 9 1994 committe discuss 1 label succinylcholin chlorid inject neuromuscular block agent new drug applic nda 8453 burrough wellcom co 8845 abbott laboratori 8847 bristol myer squibb co 80997 organon inc 2 advers experi associ administr 5 percent lidocain spinal anesthesia nda 20098 s04 astra pharmaceut product inc june 10 1994 committe hear progress report metabol lidocain human liver tissu close committe deliber committe review trade secret confidenti commerci inform relev nda 19627 ind 40 069 portion meet close permit discuss inform 5 u c 552b c 4 scienc advisori board nation center toxicolog research date time place june 14 1994 1 p june 15 1994 9 bldg 12 confer rm nation center toxicolog research nctr jefferson ar type meet contact person open committe discuss june 14 1994 1 p 5 p open board discuss june 15 1994 9 1 30 p open public hear 1 30 p 2 30 p unless public particip last long close board deliber 2 30 p 3 30 p ronald f coen nctr hft10 food drug administr 5600 fisher lane rockvil md 20857 3014433155 gener function board board advis establish implement research program assist commission food drug fulfil regulatori respons agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person june 1 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time request make comment open board discuss board conduct review scienc advisori board site visit team draft report two research program center 1 biochem molecular marker program 2 transgen program board engag discuss report come final conclus recommend made director concern center program center also provid progress report recommend two previous review research program 1 nutrit modul risk toxic program 2 appli environment microbiolog program final agenda avail begin june 7 1994 contact person close board deliber june 14 1994 board discuss person inform concern individu associ review program disclosur would constitut clearli unwarr invas person privaci portion meet close permit discuss inform 5 u c 552b c 6 ear nose throat devic panel medic devic advisori committe date time place june 27 1994 9 30 june 28 1994 8 holiday inn_silv spring plaza ballroom 8777 georgia ave silver spring md limit number overnight accommod reserv holiday inn attende requir overnight accommod must contact hotel 3015890800 refer fda panel meet block reserv confirm group rate base avail type meet contact person open public hear june 27 1994 9 30 3 p unless public particip last long open committe discuss 3 p 4 30 p close committe deliber june 28 1994 8 10 open public hear 10 11 unless public particip last long open committe discuss 11 4 30 p harri r sauberman center devic radiolog health hfz470 food drug administr 1390 piccard dr rockvil md 20850 3015942080 anyon plan attend meet need special assist defin american disabl act pleas notifi contact person gener function committe committe review evalu data safeti effect market investig devic make recommend regul agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person june 5 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss committe discuss propos protocol perform scientif clinic evalu hear aid purpos substanti manufactur perform claim close committe deliber committe discuss trade secret confidenti commerci inform portion meet close permit discuss inform 5 u c 552b c 4 dental product panel medic devic advisori committe date time place june 28 1994 10 30 june 29 1994 8 qualiti hotel maryland ballroom 8727 colesvil rd silver spring md limit number overnight accommod reserv attende requir overnight accommod must contact hotel 3015895200 refer fda panel meet block reserv confirm group rate base avail type meet contact person close committe deliber june 28 1994 10 30 4 30 p open public hear june 29 1994 8 9 unless public particip last long open committe discuss 9 6 p carolyn tylenda center devic radiolog health hfz410 food drug administr 1390 piccard dr rockvil md 3015943090 gener function committe committe review evalu data safeti effect market investig devic make recommend regul agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person june 15 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment close committe deliber committe discuss trade secret confidenti commerci inform regard pend futur devic submiss portion meet close permit discuss inform 5 u c 552b c 4 open committe discuss committe discuss classif bone fill augment materi classif dental amalgam fill materi dental product ingredi label public advisori committe meet list may mani four separ portion 1 open public hear 2 open committe discuss 3 close present data 4 close committe deliber everi advisori committe meet shall open public hear portion whether also includ three portion depend upon specif meet involv date time reserv separ portion committe meet list open public hear portion meet shall least 1 hour long unless public particip last long emphas howev 1 hour time limit open public hear repres minimum rather maximum time public particip open public hear may last whatev longer period committe chairperson determin facilit committe work public hear subject fda guidelin subpart c 21 cfr part 10 concern polici procedur electron media coverag fda public administr proceed includ hear public advisori committe 21 cfr part 14 21 cfr 10 205 repres electron media may permit subject certain limit videotap film otherwis record fda public administr proceed includ present particip meet advisori committe shall conduct insofar practic accord agenda publish feder regist notic chang agenda announc begin open portion meet interest person wish assur right make oral present open public hear portion meet shall inform contact person list either oral write prior meet person attend hear advanc meet request opportun speak allow make oral present hear conclus time permit chairperson discret agenda question address committe current list committe member avail meet locat day meet transcript open portion meet may request write freedom inform offic hfi35 food drug administr rm 12a16 5600 fisher lane rockvil md 20857 approxim 15 work day meet cost 10 cent per page transcript may view docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 approxim 15 work day meet hour 9 4 p monday friday summari minut open portion meet may request write freedom inform offic address begin approxim 90 day meet commission determin reason state portion advisori committe meet design notic shall close feder advisori committe act faca 5 u c app 2 10 permit close advisori committe meet certain circumst portion meet design close howev shall close shortest possibl time consist intent cite statut faca amend provid portion meet may close matter discuss involv trade secret commerci financi inform privileg confidenti inform person natur disclosur would clearli unwarr invas person privaci investigatori file compil law enforc purpos inform prematur disclosur would like significantli frustrat implement propos agenc action inform certain instanc gener relev fda matter exampl portion fda advisori committe meet ordinarili may close necessari accord faca criteria includ review discuss evalu draft regul guidelin similar preexist intern agenc document prematur disclosur like significantli frustrat implement propos agenc action review trade secret confidenti commerci financi inform submit agenc consider matter involv investigatori file compil law enforc purpos review matter personnel record individu patient record disclosur would constitut clearli unwarr invas person privaci exampl portion fda advisori committe meet ordinarili shall close includ review discuss evalu gener preclin clinic test protocol procedur class drug devic consider label requir class market drug devic review data inform specif investig market drug devic previous made public present data inform exempt public disclosur pursuant faca amend deliber formul advic recommend agenc matter independ justifi close notic issu section 10 1 2 feder advisori committe act 5 u c app 2 fda regul 21 cfr part 14 advisori committe date may 17 1994 summari signer linda suydam signer signjob interim deputi commission oper signjob frfile fr doc 9412493 file 52094 8 45 frfile bill bill code 416001f bill